Involvement of adenosine in the antiinflammatory action of ketamine

Anesthesiology

Volumn 102, Issue 6, 2005, Pages 1174-1181

  Mazar, Julia ^a,b,c   Rogachev, Boris ^a,c   Shaked, Gad ^a,c   Ziv, Nadav Y ^a,c   Czeiger, David ^a,c   Chaimovitz, Cidio ^a,c   Zlotnik, Moshe ^a,c   Mukmenev, Igor ^c   Byk, Gerardo ^b,c   Douvdevani, Amos ^a,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIMETHYL 7 PROPARGYLXANTHINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; TREATMENT OUTCOME;

ADENOSINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KETAMINE; MICE; NEUTROPHIL INFILTRATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; SEPSIS;

EID: 21144479972     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200506000-00017     Document Type: Article

References (27)

1. Miyasaka M, Domino EF: Neural mechanisms of ketamine-induced anesthesia. Int J Neuropharmacol 1968; 7:557-73
2. Lippmann M, Appel PL, Mok MS, Shoemaker WC: Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients. Crit Care Med 1983; 11:730-4
3. Roytblat L, Talmor D, Rachinsky M, Greemberg L, Pekar A, Appelbaum A, Gurman GM, Shapira Y, Douvdevani A: Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 1998; 87:266-71
4. Zilberstein G, Levy R, Rachinsky M, Fisher A, Greemberg L, Shapira Y, Appelbaum A, Roytblat L: Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth Analg 2002; 95:531-6
5. Koga K, Ogata M, Takenaka I, Matsumoto T, Shigematsu A: Ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan-sensitized endotoxin shock model. Circ Shock 1994; 44:160-8
6. Taniguchi T, Shibata K, Yamamoto K: Ketamine inhibits endotoxin-induced shock in rats. ANESTHESIOLOGY 2001; 95:928-32
7. Taniguchi T, Takemoto Y, Kanakura H, Kidani Y, Yamamoto K: The dose-related effects of ketamine on mortality and cytokine responses to endotoxin-induced shock in rats. Anesth Analg 2003; 97:1769-72
8. Mastronardi CA, Yu WH, McCann S: Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system. Neuroimmunomodulation 2001; 9:148-56
9. Van der Linden P, Gilbart E, Engelman E, Schmartz D, de Rood M, Vincent JL: Comparison of halothane, isoflurane, alfentanil, and ketamine in experimental septic shock. Anesth Analg 1990; 70:608-17
10. Shimaoka M, Iida T, Ohara A, Taenaka N, Mashimo T, Honda T, Yoshiya I: Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br J Anaesth 1996; 77:238-42
11. Yu Y, Zhou Z, Xu J, Liu Z, Wang Y: Ketamine reduces NFκB activation and TNFα production in rat mononuclear cells induced by lipopolysaccharide in vitro. Ann Clin Lab Sci 2002; 32:292-8
12. Kawasaki C, Kawasaki T, Ogata M, Nandate K, Shigematsu A: Ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood. Can J Anaesth 2001; 48:819-23
13. Lewis E, Rogachev B, Shaked G, Douvdevani A: The in vitro effects of ketamine at large concentrations can be attributed to a nonspecific cytostatic effect. Anesth Analg 2001; 92:927-9
14. McCallion K, Harkin DW, Gardiner KR: Role of adenosine in immunomodulation: Review of the literature. Crit Care Med 2004; 32:273-7
15. Bong GW, Rosengren S, Firestein GS: Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation: The role of N-methyl-D-aspartate receptors. J Clin Invest 1996; 98:2779-85
16. Sitkovsky MV: Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 2003; 65:493-501
17. Nithipatikom K, Mizumura T, Gross GJ: Determination of plasma adenosine by high-performance liquid chromatography with column switching and fluorometric detection. Anal Biochem 1994; 223:280-4
18. Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M: Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin Sci (Lond) 1999; 96:349-55
19. Reinhart K, Karzai W: Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned. Crit Care Med 2001; 29:5121-5
20. Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Spisani S, Cadossi R, Borea PA: Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. Br J Pharmacol 2002; 136:57-66
21. Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G, Norgauer J: Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2003; 101:3985-90
22. Hasko G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, Marton A, Szabo C: Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 2000; 14:2065-74
23. Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES: Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996; 157:4634-40
24. Majumdar S, Aggarwal BB: Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 2003; 22:1206-18
25. van Ede AE, Laan RF, De Abreu RA, Stegeman AB, van de Putte LB: Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 2002; 61:1060-4
26. Chan ES, Cronstein BN: Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002; 4:266-73
27. Cronstein BN, Montesinos MC, Weissmann G: Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB. Proc Natl Acad Sci U S A 1999; 96:6377-81